JP2024513192A - 色素沈着過剰障害を処置するための方法及び組成物 - Google Patents

色素沈着過剰障害を処置するための方法及び組成物 Download PDF

Info

Publication number
JP2024513192A
JP2024513192A JP2023560002A JP2023560002A JP2024513192A JP 2024513192 A JP2024513192 A JP 2024513192A JP 2023560002 A JP2023560002 A JP 2023560002A JP 2023560002 A JP2023560002 A JP 2023560002A JP 2024513192 A JP2024513192 A JP 2024513192A
Authority
JP
Japan
Prior art keywords
slc7a5
bch
hyperpigmentation
jph203
pigmentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023560002A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513192A5 (https=
Inventor
バロッティ，ロベール
ベルトロット，コリーヌ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Nice Sophia Antipolis UNSA
Original Assignee
Universite de Nice Sophia Antipolis UNSA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Nice Sophia Antipolis UNSA filed Critical Universite de Nice Sophia Antipolis UNSA
Publication of JP2024513192A publication Critical patent/JP2024513192A/ja
Publication of JP2024513192A5 publication Critical patent/JP2024513192A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023560002A 2021-03-30 2021-03-30 色素沈着過剰障害を処置するための方法及び組成物 Pending JP2024513192A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2021/000260 WO2022208123A1 (en) 2021-03-30 2021-03-30 Methods and compositions for treating hyperpigmentation disorders

Publications (2)

Publication Number Publication Date
JP2024513192A true JP2024513192A (ja) 2024-03-22
JP2024513192A5 JP2024513192A5 (https=) 2024-04-10

Family

ID=76250380

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023560002A Pending JP2024513192A (ja) 2021-03-30 2021-03-30 色素沈着過剰障害を処置するための方法及び組成物

Country Status (3)

Country Link
US (1) US20240197603A1 (https=)
JP (1) JP2024513192A (https=)
WO (1) WO2022208123A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3099057A1 (fr) * 2019-07-22 2021-01-29 Nunii Laboratoire Inhibiteur du transporteur LAT-1 / SLC7A5 pour son utilisation pour la régulation de la pigmentation cutanée et une composition comprenant ledit inhibiteur

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013030794A2 (en) * 2011-08-31 2013-03-07 Behrooz Kasraee Use of substituted pyridines as skin depigmenting compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3099057A1 (fr) * 2019-07-22 2021-01-29 Nunii Laboratoire Inhibiteur du transporteur LAT-1 / SLC7A5 pour son utilisation pour la régulation de la pigmentation cutanée et une composition comprenant ledit inhibiteur

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 140, JPN6025010859, 2020, pages 2253 - 2259, ISSN: 0005683613 *

Also Published As

Publication number Publication date
US20240197603A1 (en) 2024-06-20
WO2022208123A1 (en) 2022-10-06

Similar Documents

Publication Publication Date Title
US9446127B2 (en) Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss
JP7214268B2 (ja) 皮膚用組成物
JP2010132691A (ja) 乾癬及び他の皮膚疾患治療におけるシクロパミンの使用
Xu et al. Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy
KR20020035855A (ko) 약용인삼을 포함하는 뇌세포 또는 신경세포 보호제
CA3115038A1 (en) Egfr inhibitors for treating keratodermas
Song et al. Targeting a key pro-fibrotic factor S100A4 in cartilage to alleviate osteoarthritis progression and pain
WO2005065670A1 (es) Uso de la idebenona para preparar una composición despigmentante de uso tópico y composición correspondiente
IT202300003891A1 (it) Utilizzo di miriocina come adiuvante nella chirurgia del glaucoma
ES2748609T3 (es) Agonista de receptor beta-2-adrenérgico para igualar el color de las cicatrices de la piel
CN115400129A (zh) 细胞衰老表型改变用或皮肤老化防止用组合物
JP2024513192A (ja) 色素沈着過剰障害を処置するための方法及び組成物
CN110615826B (zh) 化妆料组合物及药学组合物
US20120164242A1 (en) Novel methods for modulating melanin production
JP2021522283A (ja) 分子ピンセットによるリポフスチンの凝集の阻害
US10064798B1 (en) Method for modulating pigmentation by targeting BET bromodomain proteins
WO2012105706A1 (ja) ケロイド治療剤
US20190256856A1 (en) Methods of modulating melanosome ph and melanin level in cells
FR3099057A1 (fr) Inhibiteur du transporteur LAT-1 / SLC7A5 pour son utilisation pour la régulation de la pigmentation cutanée et une composition comprenant ledit inhibiteur
US20230321004A1 (en) Methods and Compositions for Treating Melanoma and Non-Melanoma Skin Cancers
JP2024528570A (ja) 色素沈着を低下させるための組成物および方法
Ishii et al. 1226 Arctigenin (ATG)-enriched burdock seed oil (ABSO): A new ATG-enriched botanical extract with skin brightening properties
KR102682751B1 (ko) Endophilin A1 억제제를 포함하는 피부 미백용 조성물 및 피부 미백 물질의 스크리닝 방법
KR20250118815A (ko) 튜불린 저해제를 포함하는 피부 질환 예방 또는 치료용 조성물
KR20250116611A (ko) 튜불린 저해제를 포함하는 피부 질환 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240328

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240328

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250318

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250528

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250909